NCT02449889View on ClinicalTrials.gov

A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 9, 2017

Study Completion Date

March 1, 2018

Conditions
Infertility
Interventions
DRUG

highly purified human chorionic gonadotropin

DRUG

recombinant human chorionic gonadotropin

Trial Locations (1)

Unknown

Instituto Ideia Fértil de Saúde Reproductive (there may be other sites in this country), São Paulo

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY